Intravenous methylprednisolone pulse therapy in severe alopecia areata

Indian Journal of Dermatology, Venereology and Leprology

Volumn 81, Issue 1, 2015, Pages 95-

  Senila, Simona C ^a   Danescu, Sorina A ^a   Ungureanu, Loredana ^a   Candrea, Elisabeta ^a   Cosgarea, Rodica M ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Alopecia areata; Methylprednisolone; Pulse therapy

Indexed keywords

METHYLPREDNISOLONE; ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; ALOPECIA; ALOPECIA AREATA; ALOPECIA TOTALIS; ALOPECIA UNIVERSALIS; ARTICLE; ASTHENIA; CHILD; CLINICAL ARTICLE; DISEASE SEVERITY; DIZZINESS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HAIR GROWTH; HAIR LOSS; HAIR REGROWTH; HEADACHE; HEART PALPITATION; HUMAN; MALE; REPEATED DRUG DOSE; SCALP HAIR; TREATMENT DURATION; TREATMENT OUTCOME; CLINICAL TRIAL; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PRESCHOOL CHILD; PROSPECTIVE STUDY; RECURRENT DISEASE; SEVERITY OF ILLNESS INDEX; TIME; YOUNG ADULT;

ADOLESCENT; ADULT; ALOPECIA; ALOPECIA AREATA; ANTI-INFLAMMATORY AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84920837697     PISSN: 03786323     EISSN: 09733922     Source Type: Journal    
DOI: 10.4103/0378-6323.148608     Document Type: Article

References (24)

1. Ito T. Recent advances in the pathogenesis of autoimmune hair loss disease alopecia areata. Clin Dev Immunol 2013;2013:348546.
2. Kar S, Singh N. Alopecia areata treated with phenolisation and intravenous dexamethasone pulses. Int J Trichology 2013;5:47-9.
3. Burton JL, Shuster S. Large doses of glucocorticoid in the treatment of alopecia areata. Acta Derm Venereol 1975;55:493-6.
4. Wolff H. Diseases of hair. In: Burgdorf WH, Plewig G, Wolff HH, Landthaler M, editors. Braun Falco's Dermatology. 3rd ed. Heidelberg: Springer Medizin Verlag; 2009. p. 1050-2.
5. Olsen EA, Carson SC, Turney EA. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata. Arch Dermatol 1992;128:1467-73.
6. Kar BR, Handa S, Dogra S, Kumar B. Placebo-controlled oral pulse prednisolone therapy in alopecia areata. J Am Acad Dermatol 2005;52:287-90.
7. Sladden MJ, Hutchinson PE. Is oral pulsed prednisolone useful in alopecia areata? Critical appraisal of a randomized trial. J Am Acad Dermatol 2005;53:1100-1.
8. Kalin U, Hunziker T. High-dose intravenous corticosteroid pulse therapy in alopecia areata: Own experience compared with the literature. J Dtsch Dermatol Ges 2008;6:895-6.
9. Seiter S, Ugurel S, Tilgen W, Reinhold U. High-dose pulse corticosteroid therapy in the treatment of severe alopecia areata. Dermatology 2001;202:230-4.
10. Friedli A, Labarthe MP, Engelhardt E, Feldmann R, Salomon D, Saurat JH. Pulse methylprednisolone therapy for severe alopecia areata: An open prospective study of 45 patients. J Am Acad Dermatol 1998;39:597-602.
11. Luggen P, Hunziker T. High-dose intravenous corticosteroid pulse therapy in alopecia areata: Own experience compared with the literature. J Dtsch Dermatol Ges 2008;6:375-8.
12. Ito T. Advances in the management of alopecia areata. J Dermatol 2012;39:11-7.
13. Efentaki P, Altenburg A, Haerting J, Zouboulis CC. Medium-dose prednisolone pulse therapy in alopecia areata. Dermatoendocrinol 2009;1:310-3.
14. Kurosawa M, Nakagawa S, Mizuashi M, Sasaki Y, Kawamura M, Saito M, et al. A comparison of the efficacy, relapse rate and side effects among three modalities of systemic corticosteroid therapy for alopecia areata. Dermatology 2006;212:361-5.
15. Im M, Lee SS, Lee Y, Kim CD, Seo YJ, Lee JH, et al. Prognostic factors in methylprednisolone pulse therapy for alopecia areata. J Dermatol 2011;38:767-72.
16. Nakajima T, Inui S, Itami S. Pulse corticosteroid therapy for alopecia areata: Study of 139 patients. Dermatology 2007;215:320-4.
17. Uchiyama M, Egusa C, Hobo A, Irisawa R, Yamazaki M, Tsuboi R. Multivariate analysis of prognostic factors in patients with rapidly progressive alopecia areata. J Am Acad Dermatol 2012;67:1163-73.
18. Yang S, Yang J, Liu JB, Wang HY, Yang Q, Gao M, et al. The genetic epidemiology of alopecia areata in China. Br J Dermatol 2004;151:16-23.
19. Xiao FL, Yang S, Liu JB, He PP, Yang J, Cui Y, et al. The epidemiology of childhood alopecia areata in China: A study of 226 patients. Pediatr Dermatol 2006;23:13-8.
20. Cho HH, Jo SJ, Paik SH, Jeon HC, Kim KH, Eun HC, et al. Clinical characteristics and prognostic factors in early-onset alopecia totalis and alopecia universalis. J Korean Med Sci 2012;27:799-802.
21. Messenger AG, McKillop J, Farrant P, McDonagh AJ, Sladden M. British Association of Dermatologists' guidelines for the management of alopecia areata 2012. Br J Dermatol 2012;166:916-26.
22. Friedland R, Tal R, Lapidoth M, Zvulunov A, Ben Amitai D. Pulse corticosteroid therapy for alopecia areata in children: A retrospective study. Dermatology 2013;227:37-44.
23. Staumont-Sallé D, Vonarx M, Lengrand F, Segard M, Delaporte E. Pulse corticosteroid therapy for alopecia areata: Long-term outcome after 10 years. Dermatology 2012;225:81-7.
24. Olsen EA. Investigative guidelines for alopecia areata. Dermatol Ther 2011;24:311-9.